CASI Pharmaceuticals Inc. (CASI) Is Down -41.36% in 2021 With Lots of Room to Run
CASI Pharmaceuticals Inc. (NASDAQ: CASI) is -41.36% lower on its value in year-to-date trading and has touched a low of $1.46 and a high of
Tag: CASI stock
CASI Pharmaceuticals Inc. (CASI) – Don’t Believe the Hype: Check The Facts
100 institutions hold shares in CASI Pharmaceuticals Inc. (CASI), with 43.36M shares held by insiders accounting for 31.01% while institutional investors hold 43.28% of the
CASI Pharmaceuticals Inc. (CASI) Analysis & Opinions from Experts
CASI Pharmaceuticals Inc. (NASDAQ: CASI) is -38.64% lower on its value in year-to-date trading and has touched a low of $1.46 and a high of
Who is the Top Investor In CASI Pharmaceuticals Inc. (CASI)?
99 institutions hold shares in CASI Pharmaceuticals Inc. (CASI), with 43.36M shares held by insiders accounting for 31.01% while institutional investors hold 43.22% of the
New Big Money Means CASI Pharmaceuticals Inc. (CASI) Investors Could Reap Benefit
99 institutions hold shares in CASI Pharmaceuticals Inc. (CASI), with 43.36M shares held by insiders accounting for 31.01% while institutional investors hold 43.23% of the
CASI Pharmaceuticals Inc. (CASI) Review – Making Smarter Decisions
94 institutions hold shares in CASI Pharmaceuticals Inc. (CASI), with 43.36M shares held by insiders accounting for 34.98% while institutional investors hold 49.46% of the
CASI Pharmaceuticals Inc. (NASDAQ:CASI) loss -4.19% – Is It right time to buy?
How have the shares performed? CASI Pharmaceuticals Inc. (CASI) saw downtrend of -4.19% in the recent trading with $3.20 being its most recent. The current
Related Videos
